While GD2S and GD3S expression levels do not affect BC patients’ overall survival, regardless of their ER/PR/Her2 status, the high expression of CASD1 is associated with a better survival of BC patients having ER-/PR-/Her2- status. Here, ESR1 is linked to breast cancer.